期刊文献+

卵巢癌腹水中血管内皮生长因子的表达及临床意义 被引量:3

The expression and significance of ascitic vascular endothelial growth factor in epithelial ovarian cancer
下载PDF
导出
摘要 目的探讨卵巢癌恶性腹水中血管内皮生长因子(VEGF)水平与临床病理因素之间的相关性。方法采用EHSA方法检测148例卵巢癌患者恶性腹水中VEGF的表达。结果卵巢癌组腹水中VEGF表达水平为(909.16±583.15)pg/ml,显著高于良性组的(258.13±127.82)pg/ml,两组差异有统计学意义,其VEGF的表达与淋巴结转移及临床分期相关(P〈0.05)。VEGF高表达患者(≥613.38pg/m1)的生存期c(9.98±0.68)月]明显低于VEGF含量低的(〈613.38pg/m1)患者的生存期[(23.64±0.65)月],差异有统计学意义。多因素Cox回归分析结果显示腹水VEGF值与卵巢癌患者的生存期明显相关(P〈0.001)。结论腹水YEGF值可成为卵巢癌患者独立预后指标。 [Abstract] Objective To examine the expression and significance of vascular endothelial growth factor (VEGF) in ascitic fluid from patients with epithelial ovarian cancer. Methods The study included 148 consecutive ovarian cancer patients with malignant ascites. VEGF levels in ascites were determined by a sandwich enzyme-linked immunoadsorbent assay. Results In our study, we found VEGF levels in malignant ascites (909. 16 ±583.15 pg/ml) were significantly higher than those in benign ascites (258.13± 127.82 pg/ml) (P 〈0.001). Meanwhile, we also found that VEGF levels in malignant ascites were associated with TNM stage and lymphatic invasion. Patients with a high level of VEGF (≥613.38 pg/ml) in malignant ascitos exhibited poor moan survival rate [ (9.98± 0. 68) vs (23.64 ± 0. 65 ) months, P 〈 0. 001 ]. In a multivariate Cox regression model, higher ascites VEGF was an independent prognostic factor for overall survive. Conehtsion 31ae high level of VEGF value in malignant ascites may be used as an independent prognostic factor in patients with ovarian cancer.
作者 夏红慧 詹娜
出处 《中国生育健康杂志》 2016年第2期127-129,共3页 Chinese Journal of Reproductive Health
基金 湖北省自然科学基金资助项目(2013CFB255)
关键词 血管内皮生长因子 卵巢癌恶性腹水 ELISA Vascular endothelial growth factor Ovarian cancer Malignant ascites
  • 相关文献

参考文献13

  • 1Fujimoto J,Toyoki H, Sato E, et al. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer,2004,91:466-469.
  • 2Bikfalvi A. Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer, 1995,31A : 1101-1104.
  • 3Matsuyama M, Chijiwa T, lnoue Y, et al. Alternative splicing variant of vascular endothelial growth factor-A is a critical prognostic factor in non-small cell lung cancer. Oncol Rep,2009,22:1407-1413.
  • 4Otrock ZK, Makarem JA, Shamseddine AI, et al. Vascular endothelial growth factor family of ligands and receptors: Review. Blood Cells Mol Dis ,2007,38:258-268.
  • 5Raspollini MR,Amunni G,Villanucci A,et al. Prognostic significance ofmicrovessd density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma. Int J Gynecol Cancer, 2004,14 : 815 -823.
  • 6Goodheart M J, Ritchie JM, Rose SL, et al. The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer. Clin Cancer Res, 2005, 11: 3733-3742.
  • 7Hefler LA ,Zeillinger R, Grimm C, et al. Preoperative serum vascular endothelial growth factor as aprugnostie parameter in ovarian cancer. Gynecol Oncol,2006,103:512-517.
  • 8Li L,Wang L,Zhang W,et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res ,2004,24 : 1973-1979.
  • 9Rudlowski S, Pickarts AK, Fuhljahns TC, et al. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients:a long-term follow-up. Int J Gynecol Cancer, 2006,16 : 183-189.
  • 10Alcutagawa N, Nishikama A, lwasaki M,et al. Expression of vascular endothelial growth fact in human ovarian cancer association and peritoneal matastasis in house ascites model, cancer Res, 2002,93 : 644-659.

同被引文献30

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部